LGApr 20, 2021

Development of a dynamic type 2 diabetes risk prediction tool: a UK Biobank study

arXiv:2104.10108v14 citations
Originality Synthesis-oriented
AI Analysis

This provides an incremental improvement for clinical screening by enabling digital deployment without blood-based factors, targeting individuals at risk of type 2 diabetes.

The researchers developed a 10-year type 2 diabetes risk prediction tool using accessible features from the UK Biobank dataset, achieving a concordance index of 0.818 with a Cox proportional hazards model.

Diabetes affects over 400 million people and is among the leading causes of morbidity worldwide. Identification of high-risk individuals can support early diagnosis and prevention of disease development through lifestyle changes. However, the majority of existing risk scores require information about blood-based factors which are not obtainable outside of the clinic. Here, we aimed to develop an accessible solution that could be deployed digitally and at scale. We developed a predictive 10-year type 2 diabetes risk score using 301 features derived from 472,830 participants in the UK Biobank dataset while excluding any features which are not easily obtainable by a smartphone. Using a data-driven feature selection process, 19 features were included in the final reduced model. A Cox proportional hazards model slightly overperformed a DeepSurv model trained using the same features, achieving a concordance index of 0.818 (95% CI: 0.812-0.823), compared to 0.811 (95% CI: 0.806-0.815). The final model showed good calibration. This tool can be used for clinical screening of individuals at risk of developing type 2 diabetes and to foster patient empowerment by broadening their knowledge of the factors affecting their personal risk.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes